Waystar (WAY) 7th Annual Evercore ISI HealthCONx Healthcare Conference summary
Event summary combining transcript, slides, and related documents.
7th Annual Evercore ISI HealthCONx Healthcare Conference summary
11 Jan, 2026Business overview and market positioning
Went public in June 2024 with a $1 billion IPO, serving over 1 million providers and processing $1 trillion in gross claim charges annually.
Focuses on cloud-based software for healthcare providers to simplify payments and improve efficiency.
Competes in a $15 billion addressable market, winning clients with easy-to-install software and high Net Promoter Scores.
Not a services business; emphasizes a software-centric, vertically integrated approach.
Leverages transaction insights to enhance patient engagement and payment accuracy.
Growth, sales pipeline, and product traction
Sales pipeline grew throughout 2024, with over 70% win rates and momentum expected to continue into 2025.
Saw increased demand for claims management and clearinghouse solutions after a competitor's cyber attack, with automation and AI modules gaining traction.
Actively cross-sells and upsells software modules, with a focus on automation and eligibility detection.
Most new contracts are two to three years with auto-renewal, positioning as the primary clearinghouse for clients.
Competitive landscape and cybersecurity
Benefited from a competitor's cyber attack by onboarding over 30,000 providers quickly and efficiently.
Strong focus on cybersecurity, with outside advisory and rapid recovery planning.
Advocates for direct payer connections to improve network resiliency and reduce reliance on exclusive clearinghouse arrangements.
Established dozens of new direct payer connections, enhancing network effects and operational efficiency.
Latest events from Waystar
- Record FY2025 growth, 43% Q4 EBITDA margin, and strong 2026 outlook with AI momentum.WAY
Q4 202517 Feb 2026 - AI-powered automation streamlines healthcare payments, boosting efficiency and financial outcomes.WAY
Waystar True North Client Conference3 Feb 2026 - Q2 revenue up 20% to $234.5M, 40% EBITDA margin, and improved leverage ratios.WAY
Q2 20242 Feb 2026 - Modern, AI-powered platform drives growth, efficiency, and client wins amid rising cybersecurity focus.WAY
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20242 Feb 2026 - Q3 revenue up 22% to $240.1M, 40% EBITDA margin, and major debt reduction post-IPO.WAY
Q3 202416 Jan 2026 - AI-driven automation and data integration fuel growth, efficiency, and client satisfaction.WAY
44th Annual J.P. Morgan Healthcare Conference12 Jan 2026 - Strong Q3 growth, durable revenue, and 40% EBITDA margins drive market share gains.WAY
Barclays 22nd Annual Global Technology Conference 202411 Jan 2026 - AI-driven healthcare payment automation accelerates growth, efficiency, and industry leadership.WAY
43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026 - 2024 revenue up 19% with strong margins; 2025 guidance targets 7–10% growth and ongoing innovation.WAY
Q4 20246 Jan 2026